The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-center, prospective, single-arm, phase II trial to evaluate the adjuvant efficacy of camrelizumab with docetaxel plus S-1 for stage III (PD-L1+/dMMR/EBV+) gastric cancer after D2 resection.
 
Bo Ni
No Relationships to Disclose
 
Xiang Xia
No Relationships to Disclose
 
Yujing Guan
No Relationships to Disclose
 
Linxi Yang
No Relationships to Disclose
 
Linhua Ji
No Relationships to Disclose
 
Enhao Zhao
No Relationships to Disclose
 
Hui Cao
No Relationships to Disclose
 
Gang Zhao
No Relationships to Disclose
 
Chunchao Zhu
No Relationships to Disclose
 
Zizhen Zhang
No Relationships to Disclose